JLK,Inc. (KOSDAQ: 322510)

Market Cap	182.20B
Revenue (ttm)	1.62B
Net Income (ttm)	-11.27B
Shares Out	25.13M
EPS (ttm)	-592.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	191,808
Open	7,030.00
Previous Close	6,910.00
Day's Range	7,020.00 - 7,360.00
52-Week Range	6,340.00 - 22,333.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About JLK,Inc.

JLK, Inc. provides diagnosis support to the patients with it AI-driven solutions in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides the on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, coro...

• Industry: Prepackaged Software
• CEO: Dongmin Kim
• Employees: 65
• Stock Exchange: KOSDAQ
• Ticker Symbol: 322510

Financial Performance

In 2023, JLK,Inc.'s revenue was 2.49 billion, a decrease of -27.12% compared to the previous year's 3.42 billion. Losses were -7.32 billion, -18.74% less than in 2022.